Past Award Recipients:

Arthur M. Sutherland Award and Memorial Lecture

  • 2024 – Harvey Max Chochinov (Canada)
    Dr Chochinov has been an advocate internationally for a focus on meaningful care for those facing end-of-life, and area of psycho-oncology which had until his work been relatively neglected.  His ground-breaking intervention Dignity Therapy has enabled cancer clinicians across disciplines  globally to respond in a meaningful way to those facing end of life. His focus on policy and promotion of the careers of others means that he leaves an enormous and lasting legacy. Dr. Chochinov's work on Dignity Therapy, is considered one of the most important innovations in end-of-life care in psycho-oncology and palliative medicine globally. It has had immense impact through research, training, and implementation. Dr. Chochinov has authored multiple seminal textbooks that have educated practitioners worldwide and advanced the field, including Handbook of Psychiatry in Palliative Medicine and Dignity Therapy: Final Words for Final Days. His pioneering work influenced palliative care and palliative care policies globally.

  • 2023 – Barbara Andersen (USA)

  • 2022 – Dr. Maria Die Trill (Spain)
  • 2020/2021 – Dr. Paul Jacobsen (USA)
  • 2018 – Professor Richard Fielding (Hong Kong)
  • 2017 – Professor Matthew Loscalzo (USA)
  • 2016 – Dr. Barry Bultz (Canada)
  • 2015 – Dr William Redd (USA)
  • 2014 – Christoffer Johansen (Denmark)
  • 2013 – Maggie Watson (UK)
  • 2012 – Luigi Grassi* (Italy)
  • 2011 – David Spiegel (USA)
  • 2009 – William Breitbart (USA)
  • 2008 – David Kissane (Australia)
  • 2007 – Uwe Koch
  • 2006 – Peter Maguire
  • 2004 – Lea Baider (Israel)
  • 2003 – Jimmie Holland  (USA)
  • 2000 – Robert Zittoun
  • 1998 – Hiroomi Kawano
  • 1996 – Steven Greer
  • 1993 – Ned Cassem
  • 1991 – Margit von Kerekjarto
  • 1987 – Morton Bard
  • 1984 – Bernard Fox
  • 1982 – Avery Weisman

 

Bernard Fox Memorial Award

  • 2024 – Sophie Lebel (Canada)
    Dr. Sophie Lebel is a key researcher, educator and promoter in psycho-oncology. She has conducted several multi-site efficacy studies throughout the nation. She can also be viewed as a pioneer researcher in some area of psycho-oncology, such as fear of cancer recurrence (FoCR) and stigma in cancer. Her iconic works include the validation of the English version of the Fear of Cancer Recurrence Inventory (FCRI), a mostly widely used instrument to measure FCR, the co-development and testing of the Fear OF Recurrence Therapy (FORT), and she presented the first review of stigma in cancer.

  • 2023 – Anja Mehnert-Theuerkauf (Germany)
  • 2022  Dr. Electra Paskett (USA)
  • 2020/2021 – Dr. Mary Jane Esplen (Canada)
  • 2019 – Dr. Linda Carlson (Canada)
  • 2018 – Professor Brian Kelly (Australia)
  • 2017 – Dr. Gary Rodin (Canada)
  • 2016 – Kimlin Tam Ashing (USA)
  • 2015 – Dr. Susan Okjsberg Dalton (Denmark)
  • 2014 – Julia Rowland (USA)
  • 2013 – Hanneke de Haes
  • 2012 – Darius Razavi*
  • 2011 – Christoffer Johansen (Denmark)
  • 2010 – Harvey Max Chochinov (Canada)
  • 2009 – Phyllis Butow (Australia) and Ruth McCorkle
  • 2008 – Paul Jacobsen (USA)
  • 2007 – Joan Bloom (USA)
  • 2006 – Yosuke Uchitomi (Japan)
  • 2004 – Neil Aaronson (Netherlands) and David Cella
  • 2003 – Lydia Temoshok

Jimmie Holland Memorial Award Winner

  • 2024 – Lea Baider (Israel)
    Professor Lea Baider has been a true pioneer and innovator of the field of Psycho-oncology as one of its earliest leaders, scholars and influential clinicians, not only in her own country of Israel, but also internationally through her term of Presidency and many years of service on the Board of IPOS.  She has led highly creative studies of the impact of cancer on the family, initiated clinical services at two hospitals in her country, Israel, and helped create both the Israeli Psycho-oncology Society and IPOS itself. Dr Holland would be delighted to see her friend, Dr Baider, honored for her contribution with this Jimmie Holland award. Lea is indeed a senior pioneer of our field who has influenced most of us at the IPOS community and throughout the world not only by teaching us good science but also the passion of psychosocial clinical care for patients and families to whom she has dedicated her life!

  • 2023 – Maggie Watson (UK)

  • 2022 – Dr. Luzia Travado (Portugal)

  • 2020/2021 – Chioma Asuzu (Nigeria)
  • 2019 – William Breitbart (USA)

SPECIAL AWARDS

  • 2006 – Aruna Tole, Special Award for Outstanding Contributions to Clinical Care of Patients with Cancer

Hiroomi & Setsuko Kawano New Investigator Award

  • 2024 –  Jose Custers (The Netherlands)
    The research output of Dr Custers is outstanding, and her foundation work has led to the development of an intervention for those with high Fear of Cancer Recurrence (FCR).  She has tracked the course of FCR over time and has validated questionnaires for FCR. She is lead investigator on several studies and has achieved funding of over 2 million Euros which is exceptional. Impressive research output (55 papers) and funding acquisition with a clear forward-looking focus/narrative around her research program.

  • 2023 – William Rosa (USA)
  • 2022 – Dr. Lauren Heathcote (UK/USA)
  • 2020/2021 – Dr. Joanna Fardell (Australia)
  • 2019 – Dr. Ursula Sansom-Daly (Australia)
  • 2018 – Dr. Fiona Schulte, PhD (Canada)
  • 2017 – Dr. Michelle Peate (Australia)
  • 2016 – Dr. Shane Sinclair (Canada)
  • 2015 – Dr. Katrina L Whittaker
  • 2014 – Sylvie Lambert (Canada)
  • 2013 – Mariko Asai
  • 2012 – Wendy Lichtenthal (USA) and Claire Wakefield (Australia)
  • 2011 – Nadine Kasparian (USA)
  • 2010 – Maiko Fujimori (Japan)
  • 2009 – Anja Mehnert (Germany) and Alex Mitchell (UK)
  • 2008 – Susan T. Vadaparampil
  • 2007 – Wendy Wing Tak Lam (Hong Kong)
  • 2006 – Linda Carlson (Canada)
  • 2004 – Bettina Meiser
  • 2003 – Craig White
  • 1998 – Christoffer Johansen (Denmark)
  • 1996 – Yosuke Uchitomi (Japan)
  • 1993 – Elizabeth Maunsell

 

Noemi Fisman Award for Lifetime Clinical Excellence

  • 2024 – Helen Greally (Ireland)
    In her 40-year career to date, there is substantial evidence that Helen has delivered and created psycho-oncology services for thousands of patients and their families, and influenced national policy to ensure excellent clinical services across Ireland. She has played key mentoring roles and secured funding for 44 psycho-oncology posts in psychology, psychiatry, social work, and nursing, hence building up the psycho-oncology workforce and capacity. Her incredible initiative has led her to create INNOVATIVE psychooncology services for patients with a HOLISTIC APPROACH, reaching ALL TUMOR TYPES and DIFFERENT PATIENT POPULATIONS and transforming organizations to deliver better cancer care.

  • 2023 – Gil Goldzweig (Israel)
  • 2022 – Dr. Melissa Henry (Canada)
  • 2020/2021 – Dr. Jong-Heun Kim (South Korea) 
  • 2018 – Dr. Lili Tang, MD (China)
  • 2017 – Dr. Chun-Kai Fang
  • 2015 – Dr. Andrew Roth (USA)
  • 2014 – Matthew Loscalzo (USA)
  • 2013 – Andrea Farkas Patenaude (USA)
  • 2012 – David Wellisch
  • 2011 – Marguerite Lederberg
  • 2009 – Penelope Hopwood (UK)
  • 2008 – Maria Die-Trill (Spain)

 

Society Distinguished Life Fellowship Award

 

President’s Community Award for Distinguished Contributions to IPOS

  • 2019 Kim Thiboldeaux, Chief Executive Officer, Cancer Support Community 
  • 2017 – Dr. Andreas Ullrich, WHO – Noncommunicable Diseases and Mental Health Cluster
  • 2014 – Beth Diamond, President’s Community Award for Distinguished Contributions to IPOS



    *Funding support for 2012 Sutherland and Fox Awards was generously provided by Cancer Council Queensland.

    The IPOS Awards Committee shall select recipients of IPOS awards. If no suitable nominations are received, no awards will be given.

    International Psycho-Oncology Society
    1 - 189 Queen Street East
    Toronto, ON M5A 1S2

    244 Fifth Avenue, Suite L296
    New York, NY 10001

    T: +1 416-968-0260
    [email protected]



    Follow IPOS

    © 2024 International Psycho-Oncology Society 

     Website powered by Funnel Communications Inc.